<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Constitutional epimutation is one of the causes for MLH1 gene inactivation associated with hereditary non-<z:e sem="disease" ids="C0334108" disease_type="Neoplastic Process" abbrv="">polyposis</z:e> <z:hpo ids='HP_0003003'>colon cancer</z:hpo> (HNPCC) syndrome </plain></SENT>
<SENT sid="1" pm="."><plain>Here we investigate MLH1 promoter hypermethylation in 110 <z:hpo ids='HP_0003745'>sporadic</z:hpo> early-<z:hpo ids='HP_0003674'>onset</z:hpo> <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients </plain></SENT>
<SENT sid="2" pm="."><plain>Variable levels of hypermethylation were detected in 55 patients (50%) </plain></SENT>
<SENT sid="3" pm="."><plain>Importantly a reduced MLH1 gene expression was found in patients with high-level methylation, with the association of microsatellite instability (MSI) in their <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells </plain></SENT>
<SENT sid="4" pm="."><plain>Such high-level methylation accounts for 7.4% of <z:hpo ids='HP_0000001'>all</z:hpo> patients included in this study </plain></SENT>
<SENT sid="5" pm="."><plain>Furthermore, we found that in one case constitutional methylation affected both alleles, indicating a post-zygotic methylation dysregulation </plain></SENT>
<SENT sid="6" pm="."><plain>Our findings suggest that constitutional epimutation is a mechanism underlying early-<z:hpo ids='HP_0003674'>onset</z:hpo> <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, although it is involved in only a small proportion of patients, who require appropriate surveillance </plain></SENT>
<SENT sid="7" pm="."><plain>Our findings provide further insight into the role of aberrant constitutional methylation in colon <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> and raise the question of whether prevalent low-level methylation constitutes a potential risk factor for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> development </plain></SENT>
</text></document>